Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease
- 1 July 2001
- journal article
- Published by Elsevier in Kidney International
- Vol. 60 (1) , 46-54
- https://doi.org/10.1046/j.1523-1755.2001.00769.x
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Prevalence of hypertension in 1,795 subjects with chronic renal disease: The modification of diet in renal disease study baseline cohortAmerican Journal of Kidney Diseases, 1996
- Proteinuria and blood pressure as causal components of progression to end-stage renal failureNephrology Dialysis Transplantation, 1996
- Blood Pressure and End-Stage Renal Disease in MenNew England Journal of Medicine, 1996
- Angiotensin-Converting Enzyme Gene Polymorphism Is Associated With Myocardial Infarction but Not With Development of Coronary StenosisCirculation, 1995
- Early Predictors of 15-Year End-Stage Renal Disease in Hypertensive PatientsHypertension, 1995
- Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathyThe Lancet, 1993
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionNature, 1992
- Molecular basis of human hypertension: Role of angiotensinogenCell, 1992
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.Journal of Clinical Investigation, 1990
- Progression of renal insufficiency: Role of blood pressureKidney International, 1989